SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
FREMONT, Calif. & WASHINGTON--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today reported positive safety, performance and intravascular imaging ...
FREMONT, Calif., Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty ® ...
Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...
SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in the short term. Evidence on efficacy is inadequate. Therefore, ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — In patients with calcified peripheral artery disease undergoing drug-coated balloon treatment, ...
In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved, but procedure-related morbidity remains a concern. A new study published today in the Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results